Changeflow GovPing Government General K.C. Pharmaceuticals Recalls 74,016 Bottles of ...
Urgent Enforcement Amended Final

K.C. Pharmaceuticals Recalls 74,016 Bottles of Sterile Eye Drops

Favicon for changeflow.com FDA Drug Recalls (Class II)
Filed
Detected
Email

Summary

K.C. Pharmaceuticals, Inc. initiated a voluntary Class II recall of 74,016 bottles of Rugby brand Sterile Eye Drops Soothing Tears (polyethylene glycol 400 0.4% and propylene glycol 0.3%), 0.5 oz bottles. The recall was initiated on March 3, 2026, due to Lack of Assurance of Sterility. Affected lots are SY24K01 and SY24K02, both expiring 09/30/26. The FDA classified this as a Class II recall on March 31, 2026, and distribution was nationwide in the US.

Published by K.C. Pharmaceuticals on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

K.C. Pharmaceuticals initiated a voluntary Class II recall affecting 74,016 bottles of Rugby Sterile Eye Drops Soothing Tears distributed nationwide. The recall covers two lots (SY24K01 and SY24K02) expiring 09/30/26. FDA classified the recall on March 31, 2026, citing lack of assurance of sterility as the reason.

Healthcare providers, pharmacies, and retailers who received these eye drops should verify their inventory for affected lots and contact K.C. Pharmaceuticals for return instructions. Patients who have purchased this product should consult their healthcare provider if they have concerns. The recall is ongoing and consignees should monitor for updates.

Archived snapshot

Apr 16, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

K.C. Pharmaceuticals, Inc

Drug Recalls (Class II)

← All Drug Recalls (Class II) Class II D-0415-2026 · 20260408 · Ongoing · Voluntary: Firm initiated

Product

STERILE EYE DROPS SOOTHING TEARS (polyethylene glycol 400 0.4% and propylene glycol 0.3%), 0.5 OZ 0.5 fl oz (15 mL) bottles; a) Rugby LUBRICATING EYE DROPS, Distributed by: Rugby Laboratories, Liv...

Reason for Recall

Lack of Assurance of Sterility

Affected Lot Numbers / Codes

Lot: a) SY24K01, SY24K02, Exp.: 09/30/26; b) SY24K01, SY24K02, Exp.: 09/30/26.

Quantity

74,016 bottles

Firm Notification Method

E-Mail

Distribution

Nationwide in the US

Initiated

20260303

FDA Classified

20260331

Sources: openFDA · Raw JSON

Get daily alerts for FDA Drug Recalls (Class II)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from K.C. Pharmaceuticals.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
K.C. Pharmaceuticals
Filed
March 31st, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
D-0415-2026
Docket
D-0415-2026

Who this affects

Applies to
Pharmaceutical companies Healthcare providers Retailers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug recall response Market withdrawal Quality defect investigation
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Healthcare Product Safety

Get alerts for this source

We'll email you when FDA Drug Recalls (Class II) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!